CD45RO Antibody – 161Dv

Catalog: 716101                                        Clone: UCHL1                                         Isotype: Mouse IgG2a, κ
Reactivity: Human*
Storage: CD45RO antibody is supplied in antibody stabilizer with 0.05% sodium azide. Store at 4°C
IHC: CD45RO staining of FFPE human tonsil
MIBI: CD45RO staining (cyan) of FFPE human tonsil, costained with dsDNA (magenta)
IHC: CD45RO staining of FFPE human thymus
MIBI: CD45RO staining (cyan) of FFPE human thymus, costained with dsDNA (magenta)
Background: CD45RO is an isoform of CD45, a protein tyrosine phosphatase that regulates T cell receptor and B cell receptor signaling pathways. CD45RO is the shortest of the eight isoforms and is expressed on activated and memory T cells and is absent from naive T cells, making CD45RO a useful marker for differentiating T cell subsets. CD45RO is also expressed on B cell subsets, activated monocytes and macrophages. CD45RO may have prognostic value in certain cancers, including non-small cell lung cancer.

Validation: Each lot of conjugated CD45RO antibody is quality control tested by MIBIscope™ analysis of stained tissue microarrays using the appropriate positive and negative tissue field of views and are pathologist verified.

Recommended Usage: 1 uL of CD45RO antibody per 100 uL staining volume using the MIBI™ Staining Protocol.
For optimal results, antibody should be titrated for each desired application.  Suggested starting range is 1:100.

MIBI technology: Learn more about MIBI Technology, a multiplex IHC technology with unmatched sensitivity and true subcellular resolution.

References

  • Paulsen, E.E., Kilvaer, T., Khanehkenari, M.R., Maurseth, R.J., Al-Saad, S., Hald, S.M., Al-Shibli, K., Andersen, S., Richardsen, E., Busund, L.T., Bremnes, R., Donnem, T. CD45RO(+) Memory T Lymphocytes–a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer. Neoplasia. 2015;17(11):839-48.

* Conjugate tested on human tissue.

Contact Us

<p style="text-align: center; margin-top: 2em;">Let us know how we can help you.</p>


    Immuno-oncology/CancerNeuroscienceInfectious DiseaseImmunologyStem CellOther

    255

    Please contact me. I understand that I can choose to unsubscribe at any time by e-mailing marketing@ionpath.com.

    X
    Contact Us

    We are using cookies on our website

    Please confirm, if you accept our tracking cookies. You can also decline the tracking and continue to visit our website without any data sent to third-party services.